Allostatic load and risk of hearing impairment.

Ageing Allostatic load C-reactive protein Fibrinogen Haemoglobin A1c Hearing impairment Insulin-like growth factor 1 (IGF-1)

Journal

Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 22 03 2022
revised: 28 07 2022
accepted: 08 08 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 6 9 2022
Statut: epublish

Résumé

Prevention of hearing loss via addressing potentially modifiable risk factors may offer means of reducing the global burden of hearing loss. Prior studies reported associations between individual markers of inflammation and risk of hearing impairment. Allostatic load is an index of cumulative physiological stressors, including inflammation, to multiple biological systems. Our aims were to investigate associations between allostatic load and both audiometric and self-reported hearing impairment and examine whether associations are stronger over time due to prolonged high allostatic load. Data were taken from the English Longitudinal Study of Ageing (ELSA), a nationally representative study of people aged 50+ living in England over 3 time points between 2008 and 2014. Allostatic load score was comprised of thirteen different measures available at baseline and 4 years post-baseline (high-density lipoprotein/total cholesterol, triglyceride, fibrinogen, haemoglobin A1c, C-reactive protein, insulin-like growth factor 1 (IGF-1), systolic and diastolic blood pressure, mean arterial pressure, resting pulse rate, peak expiratory flow, BMI and waist circumference), measured using clinical cut-off points for normal biomarker parameters. Hearing acuity was measured with a simple handheld tone-producing device at follow-up 7 years post-baseline, while self-reported hearing impairment was measured at time point. We included samples of 4373 and 4430 for the cross-sectional and longitudinal analysis, respectively. In the cross-sectional model high allostatic load was associated both self-reported (OR = 1.08, 95% CI 1.0,1.1; p < 0.01) and objective hearing loss (OR = 1.10, 95% CI 1.1,1.2; p < 0.001) adjusting for age and sex. Cross-sectional associations between allostatic load and hearing were not significant after further adjustment for covariates (qualification, physical activity and smoking).In longitudinal modelling, high allostatic load was associated with both audiometric (Z score OR = 1.11, 95% CI 1.1,1.2; p < 0.001) and self-reported hearing impairment (OR = 1.08, 95% CI 1.0,1.1; p < 0.001) adjusting for age and sex. Allostatic load was no longer associated with self-reported hearing loss but the association with audiometric hearing impairment (OR = 1.08, 95% CI 1.03,1.13; p < 0.001) remained following additional adjustment for baseline self-reported hearing, education, physical activity, and smoking. Prolonged high allostatic load was associated with risk of hearing impairment. Reducing allostatic load via healthy lifestyle changes including non-smoking, healthy diet and exercise may offer an opportunity to reduce the risk of hearing impairment in later life.

Sections du résumé

Background UNASSIGNED
Prevention of hearing loss via addressing potentially modifiable risk factors may offer means of reducing the global burden of hearing loss. Prior studies reported associations between individual markers of inflammation and risk of hearing impairment. Allostatic load is an index of cumulative physiological stressors, including inflammation, to multiple biological systems. Our aims were to investigate associations between allostatic load and both audiometric and self-reported hearing impairment and examine whether associations are stronger over time due to prolonged high allostatic load.
Methods UNASSIGNED
Data were taken from the English Longitudinal Study of Ageing (ELSA), a nationally representative study of people aged 50+ living in England over 3 time points between 2008 and 2014. Allostatic load score was comprised of thirteen different measures available at baseline and 4 years post-baseline (high-density lipoprotein/total cholesterol, triglyceride, fibrinogen, haemoglobin A1c, C-reactive protein, insulin-like growth factor 1 (IGF-1), systolic and diastolic blood pressure, mean arterial pressure, resting pulse rate, peak expiratory flow, BMI and waist circumference), measured using clinical cut-off points for normal biomarker parameters. Hearing acuity was measured with a simple handheld tone-producing device at follow-up 7 years post-baseline, while self-reported hearing impairment was measured at time point.
Results UNASSIGNED
We included samples of 4373 and 4430 for the cross-sectional and longitudinal analysis, respectively. In the cross-sectional model high allostatic load was associated both self-reported (OR = 1.08, 95% CI 1.0,1.1; p < 0.01) and objective hearing loss (OR = 1.10, 95% CI 1.1,1.2; p < 0.001) adjusting for age and sex. Cross-sectional associations between allostatic load and hearing were not significant after further adjustment for covariates (qualification, physical activity and smoking).In longitudinal modelling, high allostatic load was associated with both audiometric (Z score OR = 1.11, 95% CI 1.1,1.2; p < 0.001) and self-reported hearing impairment (OR = 1.08, 95% CI 1.0,1.1; p < 0.001) adjusting for age and sex. Allostatic load was no longer associated with self-reported hearing loss but the association with audiometric hearing impairment (OR = 1.08, 95% CI 1.03,1.13; p < 0.001) remained following additional adjustment for baseline self-reported hearing, education, physical activity, and smoking.
Conclusions UNASSIGNED
Prolonged high allostatic load was associated with risk of hearing impairment. Reducing allostatic load via healthy lifestyle changes including non-smoking, healthy diet and exercise may offer an opportunity to reduce the risk of hearing impairment in later life.

Identifiants

pubmed: 36061925
doi: 10.1016/j.bbih.2022.100496
pii: S2666-3546(22)00086-2
pmc: PMC9429496
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100496

Subventions

Organisme : RNID
ID : G92
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Diabetes Care. 2008 Aug;31(8):1473-8
pubmed: 18540046
Lancet. 2020 Oct 17;396(10258):1135-1159
pubmed: 33069324
Ear Hear. 2020 Mar/Apr;41(2):289-299
pubmed: 31356390
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1040-1048
pubmed: 28796850
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4770-5
pubmed: 11287659
BMJ Open. 2018 Feb 1;8(2):e019615
pubmed: 29391384
Gerontologist. 2003 Oct;43(5):661-8
pubmed: 14570962
Int J Audiol. 2015;54(10):653-64
pubmed: 26070470
Ageing Res Rev. 2015 Sep;23(Pt B):154-66
pubmed: 26123097
J Speech Lang Hear Res. 2018 Apr 17;61(4):986-999
pubmed: 29610839
Am Fam Physician. 2004 Mar 1;69(5):1107-14
pubmed: 15023009
Ear Hear. 2019 Jul/Aug;40(4):981-989
pubmed: 30399011
BMC Geriatr. 2018 Oct 23;18(1):255
pubmed: 30352552
Neurosci Biobehav Rev. 2010 Sep;35(1):2-16
pubmed: 19822172
Brain Behav Immun. 2020 Jan;83:112-119
pubmed: 31562886
Soc Sci Med. 2012 Jan;74(1):75-83
pubmed: 22115943
Ann N Y Acad Sci. 2010 Feb;1186:223-39
pubmed: 20201875
J Assoc Res Otolaryngol. 2014 Aug;15(4):663-74
pubmed: 24899378
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Longit Life Course Stud. 2011;2(2):
pubmed: 24376472
Int J Audiol. 2014 Jul;53(7):469-75
pubmed: 24679110
Clin Interv Aging. 2019 Aug 14;14:1471-1480
pubmed: 31616138
Thromb Haemost. 2003 Apr;89(4):601-9
pubmed: 12669113
Sci Rep. 2017 Jun 23;7(1):4212
pubmed: 28646237
Psychosom Med. 2014 Sep;76(7):478-80
pubmed: 25141272
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):654-61
pubmed: 25477427
Psychosom Med. 2014 Sep;76(7):490-6
pubmed: 25153937
J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):207-14
pubmed: 23739996
Aging (Albany NY). 2019 Jan 4;11(1):48-62
pubmed: 30609412
BMC Med Res Methodol. 2012 Oct 29;12:164
pubmed: 23106792
Audiology. 1998 Sep-Oct;37(5):295-301
pubmed: 9776206
Exp Gerontol. 2017 Feb;88:51-58
pubmed: 27988258
Atherosclerosis. 2015 Feb;238(2):344-9
pubmed: 25555266
BMC Public Health. 2004 Apr 27;4:12
pubmed: 15113437
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Int J Epidemiol. 2001 Dec;30(6):1371-8
pubmed: 11821349
Biol Res Nurs. 2005 Jul;7(1):7-15
pubmed: 15919999
Ann N Y Acad Sci. 1998 May 1;840:33-44
pubmed: 9629234
J Aging Health. 2016 Aug;28(5):890-910
pubmed: 26553723
Disabil Health J. 2013 Jul;6(3):177-87
pubmed: 23769476
Arch Intern Med. 1997 Oct 27;157(19):2259-68
pubmed: 9343003
Ageing Res Rev. 2021 Nov;71:101423
pubmed: 34384902
Circulation. 2003 Jan 28;107(3):499-511
pubmed: 12551878
Contemp Clin Trials. 2016 Jan;46:60-66
pubmed: 26611434
Am J Epidemiol. 1999 Aug 15;150(4):341-53
pubmed: 10453810
Age Ageing. 2012 Jan;41(1):92-7
pubmed: 22086966
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Disabil Health J. 2015 Jan;8(1):51-60
pubmed: 25200711

Auteurs

Katey Matthews (K)

CMIST, Humanities Bridgeford Street Building, University of Manchester, Oxford Road, Manchester, UK.

Piers Dawes (P)

Manchester Centre for Audiology and Deafness, School of Health Sciences, University of Manchester, Manchester, UK.
Centre for Hearing Research (CHEAR), School of Health and Rehabilitation Sciences, University of Queensland, Brisbane, Australia.

Rebecca Elliot (R)

Neuroscience and Psychiatry Unit, Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.

Asri Maharani (A)

Division of Nursing, Midwifery & Social Work, University of Manchester, UK.

Neil Pendleton (N)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Gindo Tampubolon (G)

Global Development Institute and Manchester Institute for Collaborative Research on Ageing, University of Manchester, Manchester, UK.

Classifications MeSH